Loading clinical trials...
Loading clinical trials...
This study will investigate if the performance on the Montreal Cognitive Assessment (MoCA) is associated or predictive of the outcomes in voice, swallowing or upper airway therapy in the older laryngology treatment seeking patients. The relationship between the scores of MoCA and parameters in therapy will be analyzed. The outcomes of this study could potentially impact how investigators determine candidacy for therapy and develop patient treatment plans to meet their needs. This is a collaborative study with Emory Voice Center and the NYU Voice Center.
Age
60 - 110 years
Sex
ALL
Healthy Volunteers
No
UCSF Voice and Swallowing Center
San Francisco, California, United States
Emory Voice Center
Atlanta, Georgia, United States
NYU Voice Center
New York, New York, United States
Cornell Medical Center
New York, New York, United States
Start Date
March 1, 2021
Primary Completion Date
May 1, 2023
Completion Date
July 1, 2023
Last Updated
September 26, 2023
57
ACTUAL participants
Speech Therapy
BEHAVIORAL
Swallowing Therapy
BEHAVIORAL
Upper Airway Therapy
BEHAVIORAL
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04123314